91.21MMarket Cap-1.28P/E (TTM)
6.280High6.035Low484.90KVolume6.240Open6.200Pre Close2.97MTurnover4.83%Turnover RatioLossP/E (Static)15.00MShares31.01052wk High1.09P/B61.03MFloat Cap4.55052wk Low--Dividend TTM10.04MShs Float188.800Historical High--Div YieldTTM3.95%Amplitude3.862Historical Low6.129Avg Price1Lot Size
Jasper Therapeutics Stock Forum
Jasper's Briquilimab Takes Center Stage: 6 Key Data Presentations to Reveal Treatment Breakthrough at AAAAI 2025
Why is this so cheap if they rate it Strong Buy $62.78
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
Wednesday, 8th January at 7:00 am
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile
Mean change in UAS7 from baseline of -26.6 observed in the 240mg single dose cohort at 8 weeks, multiple dosing regimens ≥120mg demonstrated UAS7 change of more than -25 points
100% (N=3) Com...
No comment yet